Analytical bioconjugates, aptamers, enable specific quantitative detection of Listeria monocytogenes

• Published in: Biosensors & bioelectronics 2015-06, Vol.68, p.272-280
• Main Authors: Lee, Sang-Hee, Ahn, Ji-Young, Lee, Kyeong-Ah, Um, Hyun-Ju, Sekhon, Simranjeet Singh, Sun Park, Tae, Min, Jiho, Kim, Yang-Hoon
• Format: Article
• Language: English
• Subjects: Assaying; Bacteria; Bacterial diseases; Biosensing Techniques; Escherichia coli; Escherichia coli - isolation & purification; Humans; Listeria; Listeria monocytogenes; Listeria monocytogenes - isolation & purification; Listeria monocytogenes - pathogenicity; Listeriosis - diagnosis; Listeriosis - microbiology; Mathematical analysis; Pathogens; Platforms; Salmonella; Salmonella - isolation & purification; SELEX Aptamer Technique; Shigella; Species Specificity; Vibrio
• ISSN: 0956-5663; 1873-4235
• DOI: 10.1016/j.bios.2015.01.009

As a major human pathogen in the Listeria genus, Listeria monocytogenes causes the bacterial disease listeriosis, which is a serious infection caused by eating food contaminated with the bacteria. We have developed an aptamer-based sandwich assay (ABSA) platform that demonstrates a promising potential for use in pathogen detection using aptamers as analytical bioconjugates. The whole-bacteria SELEX (WB-SELEX) strategy was adopted to generate aptamers with high affinity and specificity against live L. monocytogenes. Of the 35 aptamer candidates tested, LMCA2 and LMCA26 reacted to L. monocytogenes with high binding, and were consequently chosen as sensing probes. The ABSA platform can significantly enhance the sensitivity by employing a very specific aptamer pair for the sandwich complex. The ABSA platform exhibited a linear response over a wide concentration range of L. monocytogenes from 20 to 2×10(6) CFU per mL and was closely correlated with the following relationship: y=9533.3x+1542.3 (R(2)=0.99). Our proposed ABSA platform also provided excellent specificity for the tests to distinguish L. monocytogenes from other Listeria species and other bacterial genera (3 Listeria spp., 4 Salmonella spp., 2 Vibrio spp., 3 Escherichia coli and 3 Shigella spp.). Improvements in the sensitivity and specificity have not only facilitated the reliable detection of L. monocytogenes at extremely low concentrations, but also allowed for the development of a 96-well plate-based routine assay platform for multivalent diagnostics.